社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
HoSei
IP属地：未知
+关注
帖子 · 27
帖子 · 27
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
HoSei
HoSei
·
2021-11-29
The new COVID-19 variant is bad news for the rest of the markets…
Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week<blockquote>Moderna、辉瑞和 Novavax 是本周必备股票</blockquote>
The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday
Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week<blockquote>Moderna、辉瑞和 Novavax 是本周必备股票</blockquote>
看
4,502
回复
评论
点赞
4
编组 21备份 2
分享
举报
HoSei
HoSei
·
2021-11-28
Down for 2 days in a row is serious for a reputable bank like DBS, no wonder MAS is stepping in.
非常抱歉，此主贴已删除
看
3,839
回复
评论
点赞
2
编组 21备份 2
分享
举报
HoSei
HoSei
·
2021-11-12
It is still a great buy for me at $22-24
Analysts Adjust Palantir Price Targets Post Q3 Results<blockquote>分析师在第三季度业绩公布后调整 Palantir 价格目标</blockquote>
Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat. RBC Ca
Analysts Adjust Palantir Price Targets Post Q3 Results<blockquote>分析师在第三季度业绩公布后调整 Palantir 价格目标</blockquote>
看
2,895
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
HoSei
HoSei
·
2021-11-10
$24 range is a Great buy
Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y<blockquote>Palantir 预计 2021 财年收入增长 40%；第三季度美国商业收入同比增长103%</blockquote>
Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended
Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y<blockquote>Palantir 预计 2021 财年收入增长 40%；第三季度美国商业收入同比增长103%</blockquote>
看
3,465
回复
评论
点赞
3
编组 21备份 2
分享
举报
HoSei
HoSei
·
2021-11-09
$Palantir Technologies Inc.(PLTR)$
Pay day!
看
3,780
回复
评论
点赞
1
编组 21备份 2
分享
举报
HoSei
HoSei
·
2021-11-09
$Pinterest, Inc.(PINS)$
Share share
看
3,347
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
HoSei
HoSei
·
2021-11-06
$Pinterest, Inc.(PINS)$
Share
看
2,979
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
HoSei
HoSei
·
2021-11-05
$Palantir Technologies Inc.(PLTR)$
Share
看
3,106
回复
评论
点赞
1
编组 21备份 2
分享
举报
HoSei
HoSei
·
2021-11-05
$Pinterest, Inc.(PINS)$
Too good to miss
看
3,298
回复
评论
点赞
1
编组 21备份 2
分享
举报
HoSei
HoSei
·
2021-11-04
$Palantir Technologies Inc.(PLTR)$
To the moon tonight
看
2,935
回复
评论
点赞
2
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3579647754039667","uuid":"3579647754039667","gmtCreate":1616554047033,"gmtModify":1617250465419,"name":"HoSei","pinyin":"hosei","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":106,"tweetSize":27,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.01","exceedPercentage":"93.61%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.96%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":600561028,"gmtCreate":1638175738678,"gmtModify":1638175771458,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"The new COVID-19 variant is bad news for the rest of the markets…","listText":"The new COVID-19 variant is bad news for the rest of the markets…","text":"The new COVID-19 variant is bad news for the rest of the markets…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600561028","repostId":"1119853738","repostType":4,"repost":{"id":"1119853738","kind":"news","pubTimestamp":1638153494,"share":"https://www.laohunote.com/m/news/1119853738?lang=zh_CN&edition=full","pubTime":"2021-11-29 10:38","market":"us","language":"en","title":"Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week<blockquote>Moderna、辉瑞和 Novavax 是本周必备股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119853738","media":"Motley Fool","summary":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday","content":"<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.</p><p><blockquote>上周五，新出现的奥密克戎冠状病毒变种给美国股市带来了冲击波。奥密克戎让世界感到紧张，因为它独特的突变组合可能会显着降低第一代新冠肺炎疫苗的有效性。</blockquote></p><p> While there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.</p><p><blockquote>虽然根本没有足够的数据来对奥密克戎变种的严重性得出任何明确的结论，但世界各地的政界人士迅速做出反应，在周末对几个非洲国家实施了旅行禁令和限制。这些快速的旅行限制非常清楚地表明，全球疫情及其对世界经济的影响远未结束。</blockquote></p><p> How should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers <b>Moderna</b>(NASDAQ:MRNA),<b>Pfizer</b>(NYSE:PFE), and <b>Novavax</b>(NASDAQ:NVAX) all vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.</p><p><blockquote>投资者应该如何保护他们的投资组合免受这一对全球供应链、国际旅行和公共健康的最新威胁？答案似乎很简单：疫苗库存。黑色星期五，顶级 COVID-19 疫苗开发商的股票<b>现代</b>（纳斯达克股票代码：MRNA），<b>辉瑞</b>（纽约证券交易所代码：PFE），以及<b>诺瓦瓦克斯</b>（纳斯达克股票代码：NVAX）均大幅走高。这就是这三只生物制药股寻求在下周及以后继续北上的原因。</blockquote></p><p> The pandemic's latest twist makes these three stocks screaming buys</p><p><blockquote>大流行的最新转折让这三只股票尖叫着买入</blockquote></p><p> Moderna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.</p><p><blockquote>由于对奥密克戎变种的快速反应，Moderna、辉瑞和Novavax的股价在周五假期缩短的交易时段都大幅上涨。具体来说，Moderna宣布，它正在研究一种奥密克戎特异性疫苗，以及一种基于其目前授权的新冠肺炎疫苗的独特加强注射方案，这可能会为这种新变种提供更高水平的免疫保护。</blockquote></p><p> Pfizer, for its part, said that its <b>BioNTech</b>-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.</p><p><blockquote>辉瑞公司则表示，其<b>生物技术</b>-合作的 COVID-19 疫苗可以轻松适应奥密克戎变种，并在 100 天内准备好使用——也就是说，如果其疫苗的原始版本无法提供足够的保护。Novavax 上周五还提供了其奥密克戎疫苗战略的最新情况，该生物技术公司表示，计划在未来几周内准备一种针对奥密克戎的疫苗进行测试和生产。</blockquote></p><p> Why are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.</p><p><blockquote>为什么这些奥密克戎定制的疫苗对它们的开发者来说是一个巨大的利好？在此消息发布之前，Moderna和辉瑞/BioNTech的信使RNA（mRNA）疫苗似乎都处于商业保质期的后端。因此，Moderna 的股票在本月早些时候处于明显的下跌趋势。对更有效的加强注射和潜在的变异特异性疫苗的突然需求应该会让 Moderna 的营收在 2022 年保持正确的方向，这应该会在今年剩余时间里点燃这家生物技术公司的股价之火。</blockquote></p><p> While Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.</p><p><blockquote>虽然辉瑞的股价最近没有因为口服冠状病毒药丸而跳动，但这家制药巨头现在可能会受益于又一年异常强劲的 COVID-19 疫苗销售。反过来，辉瑞的股价可能会在 2022 年继续创下不断增长的历史新高。</blockquote></p><p> On the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have dipped in the back half of 2021 in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.</p><p><blockquote>在 ledger 的 Novavax 方面，这家生物技术公司的股价目前较 52 周高点下跌了 31%。由于制造问题、监管延误以及投资者越来越担心该公司可能错失良机，这家疫苗专家的股价在 2021 年下半年下跌。</blockquote></p><p> What's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.</p><p><blockquote>重要的是要明白，Novavax的新冠肺炎疫苗是基于蛋白质的，这可能会吸引对尖端mRNA疫苗犹豫不决的广大民众。因此，随着该公司在至关重要的美国市场慢慢完成监管流程，这种新变体应该会保持对 Novavax 替代疫苗的潜在需求偏高。</blockquote></p><p> In short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.</p><p><blockquote>简而言之，Moderna、辉瑞和Novavax都将从其独特的疫苗开发能力中受益匪浅，这使得它们的股票在本周成为极其强劲的买盘。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week<blockquote>Moderna、辉瑞和 Novavax 是本周必备股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Pfizer, and Novavax Are Must-Own Stocks This Week<blockquote>Moderna、辉瑞和 Novavax 是本周必备股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-11-29 10:38</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.</p><p><blockquote>上周五，新出现的奥密克戎冠状病毒变种给美国股市带来了冲击波。奥密克戎让世界感到紧张，因为它独特的突变组合可能会显着降低第一代新冠肺炎疫苗的有效性。</blockquote></p><p> While there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.</p><p><blockquote>虽然根本没有足够的数据来对奥密克戎变种的严重性得出任何明确的结论，但世界各地的政界人士迅速做出反应，在周末对几个非洲国家实施了旅行禁令和限制。这些快速的旅行限制非常清楚地表明，全球疫情及其对世界经济的影响远未结束。</blockquote></p><p> How should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers <b>Moderna</b>(NASDAQ:MRNA),<b>Pfizer</b>(NYSE:PFE), and <b>Novavax</b>(NASDAQ:NVAX) all vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.</p><p><blockquote>投资者应该如何保护他们的投资组合免受这一对全球供应链、国际旅行和公共健康的最新威胁？答案似乎很简单：疫苗库存。黑色星期五，顶级 COVID-19 疫苗开发商的股票<b>现代</b>（纳斯达克股票代码：MRNA），<b>辉瑞</b>（纽约证券交易所代码：PFE），以及<b>诺瓦瓦克斯</b>（纳斯达克股票代码：NVAX）均大幅走高。这就是这三只生物制药股寻求在下周及以后继续北上的原因。</blockquote></p><p> The pandemic's latest twist makes these three stocks screaming buys</p><p><blockquote>大流行的最新转折让这三只股票尖叫着买入</blockquote></p><p> Moderna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.</p><p><blockquote>由于对奥密克戎变种的快速反应，Moderna、辉瑞和Novavax的股价在周五假期缩短的交易时段都大幅上涨。具体来说，Moderna宣布，它正在研究一种奥密克戎特异性疫苗，以及一种基于其目前授权的新冠肺炎疫苗的独特加强注射方案，这可能会为这种新变种提供更高水平的免疫保护。</blockquote></p><p> Pfizer, for its part, said that its <b>BioNTech</b>-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.</p><p><blockquote>辉瑞公司则表示，其<b>生物技术</b>-合作的 COVID-19 疫苗可以轻松适应奥密克戎变种，并在 100 天内准备好使用——也就是说，如果其疫苗的原始版本无法提供足够的保护。Novavax 上周五还提供了其奥密克戎疫苗战略的最新情况，该生物技术公司表示，计划在未来几周内准备一种针对奥密克戎的疫苗进行测试和生产。</blockquote></p><p> Why are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.</p><p><blockquote>为什么这些奥密克戎定制的疫苗对它们的开发者来说是一个巨大的利好？在此消息发布之前，Moderna和辉瑞/BioNTech的信使RNA（mRNA）疫苗似乎都处于商业保质期的后端。因此，Moderna 的股票在本月早些时候处于明显的下跌趋势。对更有效的加强注射和潜在的变异特异性疫苗的突然需求应该会让 Moderna 的营收在 2022 年保持正确的方向，这应该会在今年剩余时间里点燃这家生物技术公司的股价之火。</blockquote></p><p> While Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.</p><p><blockquote>虽然辉瑞的股价最近没有因为口服冠状病毒药丸而跳动，但这家制药巨头现在可能会受益于又一年异常强劲的 COVID-19 疫苗销售。反过来，辉瑞的股价可能会在 2022 年继续创下不断增长的历史新高。</blockquote></p><p> On the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have dipped in the back half of 2021 in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.</p><p><blockquote>在 ledger 的 Novavax 方面，这家生物技术公司的股价目前较 52 周高点下跌了 31%。由于制造问题、监管延误以及投资者越来越担心该公司可能错失良机，这家疫苗专家的股价在 2021 年下半年下跌。</blockquote></p><p> What's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.</p><p><blockquote>重要的是要明白，Novavax的新冠肺炎疫苗是基于蛋白质的，这可能会吸引对尖端mRNA疫苗犹豫不决的广大民众。因此，随着该公司在至关重要的美国市场慢慢完成监管流程，这种新变体应该会保持对 Novavax 替代疫苗的潜在需求偏高。</blockquote></p><p> In short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.</p><p><blockquote>简而言之，Moderna、辉瑞和Novavax都将从其独特的疫苗开发能力中受益匪浅，这使得它们的股票在本周成为极其强劲的买盘。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119853738","content_text":"The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significantly reduce the effectiveness of first-generation COVID-19 vaccines.\nWhile there simply isn't enough data to draw any firm conclusions about the seriousness of the omicron variant yet, politicians across the world were quick to react by imposing travel bans and restrictions on several African nations over the weekend. These rapid-fire travel restrictions make it abundantly clear that the global pandemic -- and its effects on the world economy -- are far from over.\nHow should investors protect their portfolios from this latest threat to global supply chains, international travel, and public health? The answer appears to be simple enough: vaccine stocks. On Black Friday, shares of the top COVID-19 vaccine developers Moderna(NASDAQ:MRNA),Pfizer(NYSE:PFE), and Novavax(NASDAQ:NVAX) all vaulted higher. Here's why these threebiopharmaceutical stocksought to continue to their march northward next week and beyond.\nThe pandemic's latest twist makes these three stocks screaming buys\nModerna, Pfizer, and Novavax all enjoyed a sizable jump in their share prices during the holiday-shortened trading session on Friday thanks to their quick reaction to the omicron variant. Specifically, Moderna announced that it is working on an omicron-specific vaccine, as well a unique booster shot regimen, based on its currently authorized COVID-19 vaccine, that may provide a higher level of immune protection against this new variant.\nPfizer, for its part, said that its BioNTech-partnered COVID-19 vaccine can easily be tailored to the omicron variant and be ready for use within 100-days -- that is, if the original version of its vaccine fails to provide adequate protection. Novavax also provided an update on its omicron vaccine strategy last Friday, with the biotech saying that it plans on having an omicron-specific shot ready for testing and manufacturing within the next few weeks.\nWhy are these omicron-tailored vaccines a huge positive for their developers? The messenger RNA (mRNA) vaccines from Moderna and Pfizer/BioNTech both appeared to be on the back end of the commercial shelf lives prior to this news. As a result, Moderna's stock was in the midst of notable downward trend earlier this month. The sudden need for more potent booster shots and a potential variant-specific vaccine should keep Moderna's top line headed in the right direction in 2022, which ought to light a fire underneath the biotech's shares for the remainder of the year.\nWhile Pfizer's equity hasn't skipped a beat of late because of its oral coronavirus pill, the pharma giant now stands to possibly benefit from another year of exceptionally strong COVID-19 vaccine sales. Pfizer's stock, in turn, will probably continue to print ever-increasing record highs heading into 2022.\nOn the Novavax side of ledger, the biotech's shares are currently down by a whopping 31% from their 52-week highs. The vaccine specialist's shares have dipped in the back half of 2021 in response to manufacturing issues, regulatory delays, and a growing concern among investors that the company may have simply missed the boat.\nWhat's important to understand is that Novavax's COVID-19 vaccine is protein-based, which may appeal to a broad range of folks hesitant about cutting-edge mRNA vaccines. This new variant, therefore, ought to keep this latent demand for Novavax's alternative jab on the high side, as the company slowly completes the regulatory process in the all-important U.S. market.\nIn short, Moderna, Pfizer, and Novavax are all poised to benefit in a big way from their unique vaccine development capabilities, making their stocks exceedingly strong buys this week.","news_type":1,"symbols_score_info":{"NVAX":0.9,"PFE":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":4502,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600964410,"gmtCreate":1638056677188,"gmtModify":1638063470923,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"Down for 2 days in a row is serious for a reputable bank like DBS, no wonder MAS is stepping in.","listText":"Down for 2 days in a row is serious for a reputable bank like DBS, no wonder MAS is stepping in.","text":"Down for 2 days in a row is serious for a reputable bank like DBS, no wonder MAS is stepping in.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600964410","repostId":"1113757092","repostType":4,"isVote":1,"tweetType":1,"viewCount":3839,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879035089,"gmtCreate":1636669247252,"gmtModify":1636669247382,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"It is still a great buy for me at $22-24","listText":"It is still a great buy for me at $22-24","text":"It is still a great buy for me at $22-24","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879035089","repostId":"1139881214","repostType":2,"repost":{"id":"1139881214","kind":"news","pubTimestamp":1636619165,"share":"https://www.laohunote.com/m/news/1139881214?lang=zh_CN&edition=full","pubTime":"2021-11-11 16:26","market":"us","language":"en","title":"Analysts Adjust Palantir Price Targets Post Q3 Results<blockquote>分析师在第三季度业绩公布后调整 Palantir 价格目标</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1139881214","media":"Benzinga","summary":"Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Ca","content":"<p><div> Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat. RBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, ...</p><p><blockquote><div>尽管第三季度表现强劲，但很少有分析师下调 Palantir Technologies Inc（纽约证券交易所股票代码：PLTR）的目标价。加拿大皇家银行资本分析师 Rishi Jaluria 将行业表现评级下调至表现不佳，目标价为 19 美元，……</div></blockquote></p><p> <a href=\"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html\">网页链接</a> </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html\">网页连接</a></blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Analysts Adjust Palantir Price Targets Post Q3 Results<blockquote>分析师在第三季度业绩公布后调整 Palantir 价格目标</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnalysts Adjust Palantir Price Targets Post Q3 Results<blockquote>分析师在第三季度业绩公布后调整 Palantir 价格目标</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-11 16:26</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat. RBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, ...</p><p><blockquote><div>尽管第三季度表现强劲，但很少有分析师下调 Palantir Technologies Inc（纽约证券交易所股票代码：PLTR）的目标价。加拿大皇家银行资本分析师 Rishi Jaluria 将行业表现评级下调至表现不佳，目标价为 19 美元，……</div></blockquote></p><p> <a href=\"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html\">网页链接</a> </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139881214","content_text":"Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, down from $25, implying a 17% downside.\nThe analyst cites the company's \"mixed\" Q3 results with deceleration in the government business while noting that its commercial acceleration that is being fueled by SPAC investments is \"unsustainable.\"\nJaluria adds that his confidence in Palantr's 30% growth is reduced, and he sees the stock's valuation as \"full.\"\nWilliam Blair analyst Kamil Mielczarek says Palantir revenues decelerated in the quarter to 36% year-over-year, down from 49% in the first half of 2021.\nWhile Palantir delivered \"strong\" headline numbers, the growth in the second half of 2021 is \"heavily reliant on strategic investments.\"\nThe analyst remains concerned about the business's ability to maintain 30% organic growth over the near term and keeps an Underperform rating on Palantir.\nCiti analyst Tyler Radke states Palantir's decelerating growth \"came into center view\" in Q3 with weakness in both commercial and government.\nWhile guidance for Q4 was issued slightly ahead of the Street, it still implies slower growth, even on an easier comparison and with significant tailwinds from SPAC-related customer contracting.\nHe reiterates a Sell rating on the shares with an $18 price target.\nWolfe Research analyst Alex Zukin lowered the price target to $20 from $25, and maintained a Peer Perform following what he calls an \"interesting\" Q3 report.\nHe notes that shares were down after the announcement, which he blames a \"meaningful top-line deceleration,\" pointing out that total revenues, ex. SPAC-contributions of $373 million grew 29% year-over-year, which Zukin said is up only less than $1 million sequentially from Q2.\nHis lower price target is due to the core growth deceleration as he is \"not yet comfortable assigning a similar confidence interval and multiple to SPAC-based commercial revenue.\"\nMorgan Stanley analyst Keith Weiss raised the price target to $24 from $22, implying a 4% upside.\nHe reiterated an Underweight after delivering another beat versus consensus expectations \"across all key headline metrics\" in Q3.\nWeiss sees \"signs of slowing underneath the hood\" as a slowdown in core revenue and commercial growth, coupled with a sharper slowdown in the government segment, which opens up the debate on the durability of Palantir's growth.\nPrice Action:PLTR shares traded lower by 5.6% at $22.9 on the last check Wednesday.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":2895,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847242787,"gmtCreate":1636529421946,"gmtModify":1636529422091,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"$24 range is a Great buy","listText":"$24 range is a Great buy","text":"$24 range is a Great buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847242787","repostId":"1105674649","repostType":2,"repost":{"id":"1105674649","kind":"news","pubTimestamp":1636459675,"share":"https://www.laohunote.com/m/news/1105674649?lang=zh_CN&edition=full","pubTime":"2021-11-09 20:07","market":"us","language":"en","title":"Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y<blockquote>Palantir 预计 2021 财年收入增长 40%；第三季度美国商业收入同比增长103%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1105674649","media":"businesswire","summary":"Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended","content":"<p>Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended September 30, 2021.</p><p><blockquote>Palantir Technologies Inc.（纽约证券交易所股票代码：PLTR）今天公布了截至2021年9月30日的第三季度财务业绩。</blockquote></p><p> <b>Q3 2021 Highlights</b></p><p><blockquote><b>2021 年第三季度亮点</b></blockquote></p><p> <ul> <li>Total revenue grew 36% year-over-year to $392 million</li> <li>Added 34 net new customers in Q3</li> <li>Commercial customer count grew 46% quarter-over-quarter</li> <li>US commercial revenue grew 103% year-over-year</li> <li>Cash flow from operations of $101 million, representing a 26% margin</li> <li>Adjusted free cash flow of $119 million, representing a 30% margin</li> <li>Closed 54 deals of $1 million or more, of which:</li> <li>Total remaining deal value grew 50% year-over-year to $3.6 billion</li> <li>GAAP net loss per share, diluted of $(0.05)</li> <li>Adjusted earnings per share, diluted of $0.04</li> </ul> <b>Q1-Q3 2021 Highlights</b></p><p><blockquote><ul><li>总收入同比增长 36% 至 3.92 亿美元</li><li>第三季度净增34家新客户</li><li>商业客户数量环比增长 46%</li><li>美国商业收入同比增长103%</li><li>经营现金流为 1.01 亿美元，利润率为 26%</li><li>调整后自由现金流为 1.19 亿美元，利润率为 30%</li><li>完成 54 笔 100 万美元或以上的交易，其中：</li><li>剩余交易总价值同比增长 50%，达到 36 亿美元</li><li>GAAP 稀释后每股净亏损为 $(0.05)</li><li>调整后每股收益（稀释后）为 0.04 美元</li></ul><b>2021年第一季度至第三季度亮点</b></blockquote></p><p> <ul> <li>Total revenue grew 44% year-over-year to $1.1 billion</li> <li>Commercial customer count increased 135% since December 31, 2020</li> <li>Cash flow from operations of $240 million, representing a 22% margin</li> <li>Adjusted free cash flow of $320 million, representing a 29% margin</li> </ul> <b>Q3 2021 Financial Summary</b></p><p><blockquote><ul><li>总收入同比增长 44% 至 11 亿美元</li><li>自2020年12月31日以来，商业客户数量增加了135%</li><li>经营现金流为 2.4 亿美元，利润率为 22%</li><li>调整后自由现金流为 3.2 亿美元，利润率为 29%</li></ul><b>2021 年第三季度财务摘要</b></blockquote></p><p> <img src=\"https://static.tigerbbs.com/658b280b0509d4e5fe970e5de61570e5\" tg-width=\"985\" tg-height=\"494\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <table> <tbody> <tr></tr> <tr></tr> </tbody> </table> <b>Outlook</b></p><p><blockquote><table><tbody><tr></tr><tr></tr></tbody></table><b>世界观</b></blockquote></p><p> For Q4 2021, we expect:</p><p><blockquote>2021 年第四季度，我们预计：</blockquote></p><p> <ul> <li>$418 million in revenue.</li> <li>Adjusted operating margin of 22%.</li> </ul> For full year 2021:</p><p><blockquote><ul><li>收入4.18亿美元。</li><li>调整后营业利润率为 22%。</li></ul>二零二一年全年：</blockquote></p><p> <ul> <li>We expect revenue growth of 40% to $1.527 billion.</li> <li>We are raising our outlook for adjusted free cash flow to in excess of $400 million, up from in excess of $300 million.</li> </ul> Per long-term guidance policy, as provided by our Chief Executive Officer, Alex Karp, we continue to expect:</p><p><blockquote><ul><li>我们预计收入将增长 40%，达到 15.27 亿美元。</li><li>我们将调整后自由现金流的预期从超过 3 亿美元上调至超过 4 亿美元。</li></ul>根据我们首席执行官 Alex Karp 提供的长期指导政策，我们继续预计：</blockquote></p><p> <ul> <li>Annual revenue growth of 30% or greater for 2021 through 2025.</li> </ul> Palantir shares once rose nearly 5% in premarket trading.<img src=\"https://static.tigerbbs.com/ca256a464d04c12064d041bcfbdf1049\" tg-width=\"894\" tg-height=\"602\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>从2021年到2025年，年收入增长30%或更高。</li></ul>Palantir 股价在盘前交易中一度上涨近 5%。</blockquote></p><p></p>","source":"lsy1584686423112","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y<blockquote>Palantir 预计 2021 财年收入增长 40%；第三季度美国商业收入同比增长103%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Expects 40% Revenue Growth in FY 2021; Q3 US Commercial Revenue up 103% Y/Y<blockquote>Palantir 预计 2021 财年收入增长 40%；第三季度美国商业收入同比增长103%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">businesswire</strong><span class=\"h-time small\">2021-11-09 20:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended September 30, 2021.</p><p><blockquote>Palantir Technologies Inc.（纽约证券交易所股票代码：PLTR）今天公布了截至2021年9月30日的第三季度财务业绩。</blockquote></p><p> <b>Q3 2021 Highlights</b></p><p><blockquote><b>2021 年第三季度亮点</b></blockquote></p><p> <ul> <li>Total revenue grew 36% year-over-year to $392 million</li> <li>Added 34 net new customers in Q3</li> <li>Commercial customer count grew 46% quarter-over-quarter</li> <li>US commercial revenue grew 103% year-over-year</li> <li>Cash flow from operations of $101 million, representing a 26% margin</li> <li>Adjusted free cash flow of $119 million, representing a 30% margin</li> <li>Closed 54 deals of $1 million or more, of which:</li> <li>Total remaining deal value grew 50% year-over-year to $3.6 billion</li> <li>GAAP net loss per share, diluted of $(0.05)</li> <li>Adjusted earnings per share, diluted of $0.04</li> </ul> <b>Q1-Q3 2021 Highlights</b></p><p><blockquote><ul><li>总收入同比增长 36% 至 3.92 亿美元</li><li>第三季度净增34家新客户</li><li>商业客户数量环比增长 46%</li><li>美国商业收入同比增长103%</li><li>经营现金流为 1.01 亿美元，利润率为 26%</li><li>调整后自由现金流为 1.19 亿美元，利润率为 30%</li><li>完成 54 笔 100 万美元或以上的交易，其中：</li><li>剩余交易总价值同比增长 50%，达到 36 亿美元</li><li>GAAP 稀释后每股净亏损为 $(0.05)</li><li>调整后每股收益（稀释后）为 0.04 美元</li></ul><b>2021年第一季度至第三季度亮点</b></blockquote></p><p> <ul> <li>Total revenue grew 44% year-over-year to $1.1 billion</li> <li>Commercial customer count increased 135% since December 31, 2020</li> <li>Cash flow from operations of $240 million, representing a 22% margin</li> <li>Adjusted free cash flow of $320 million, representing a 29% margin</li> </ul> <b>Q3 2021 Financial Summary</b></p><p><blockquote><ul><li>总收入同比增长 44% 至 11 亿美元</li><li>自2020年12月31日以来，商业客户数量增加了135%</li><li>经营现金流为 2.4 亿美元，利润率为 22%</li><li>调整后自由现金流为 3.2 亿美元，利润率为 29%</li></ul><b>2021 年第三季度财务摘要</b></blockquote></p><p> <img src=\"https://static.tigerbbs.com/658b280b0509d4e5fe970e5de61570e5\" tg-width=\"985\" tg-height=\"494\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <table> <tbody> <tr></tr> <tr></tr> </tbody> </table> <b>Outlook</b></p><p><blockquote><table><tbody><tr></tr><tr></tr></tbody></table><b>世界观</b></blockquote></p><p> For Q4 2021, we expect:</p><p><blockquote>2021 年第四季度，我们预计：</blockquote></p><p> <ul> <li>$418 million in revenue.</li> <li>Adjusted operating margin of 22%.</li> </ul> For full year 2021:</p><p><blockquote><ul><li>收入4.18亿美元。</li><li>调整后营业利润率为 22%。</li></ul>二零二一年全年：</blockquote></p><p> <ul> <li>We expect revenue growth of 40% to $1.527 billion.</li> <li>We are raising our outlook for adjusted free cash flow to in excess of $400 million, up from in excess of $300 million.</li> </ul> Per long-term guidance policy, as provided by our Chief Executive Officer, Alex Karp, we continue to expect:</p><p><blockquote><ul><li>我们预计收入将增长 40%，达到 15.27 亿美元。</li><li>我们将调整后自由现金流的预期从超过 3 亿美元上调至超过 4 亿美元。</li></ul>根据我们首席执行官 Alex Karp 提供的长期指导政策，我们继续预计：</blockquote></p><p> <ul> <li>Annual revenue growth of 30% or greater for 2021 through 2025.</li> </ul> Palantir shares once rose nearly 5% in premarket trading.<img src=\"https://static.tigerbbs.com/ca256a464d04c12064d041bcfbdf1049\" tg-width=\"894\" tg-height=\"602\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>从2021年到2025年，年收入增长30%或更高。</li></ul>Palantir 股价在盘前交易中一度上涨近 5%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.businesswire.com/news/home/20211109005487/en/Palantir-Expects-40-Revenue-Growth-in-FY-2021-Q3-US-Commercial-Revenue-up-103-YY\">businesswire</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://www.businesswire.com/news/home/20211109005487/en/Palantir-Expects-40-Revenue-Growth-in-FY-2021-Q3-US-Commercial-Revenue-up-103-YY","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105674649","content_text":"Palantir Technologies Inc. (NYSE:PLTR) today announced financial results for the third quarter ended September 30, 2021.\nQ3 2021 Highlights\n\nTotal revenue grew 36% year-over-year to $392 million\nAdded 34 net new customers in Q3\nCommercial customer count grew 46% quarter-over-quarter\nUS commercial revenue grew 103% year-over-year\nCash flow from operations of $101 million, representing a 26% margin\nAdjusted free cash flow of $119 million, representing a 30% margin\nClosed 54 deals of $1 million or more, of which:\nTotal remaining deal value grew 50% year-over-year to $3.6 billion\nGAAP net loss per share, diluted of $(0.05)\nAdjusted earnings per share, diluted of $0.04\n\nQ1-Q3 2021 Highlights\n\nTotal revenue grew 44% year-over-year to $1.1 billion\nCommercial customer count increased 135% since December 31, 2020\nCash flow from operations of $240 million, representing a 22% margin\nAdjusted free cash flow of $320 million, representing a 29% margin\n\nQ3 2021 Financial Summary\n\n\n\n\n\n\n\nOutlook\nFor Q4 2021, we expect:\n\n$418 million in revenue.\nAdjusted operating margin of 22%.\n\nFor full year 2021:\n\nWe expect revenue growth of 40% to $1.527 billion.\nWe are raising our outlook for adjusted free cash flow to in excess of $400 million, up from in excess of $300 million.\n\nPer long-term guidance policy, as provided by our Chief Executive Officer, Alex Karp, we continue to expect:\n\nAnnual revenue growth of 30% or greater for 2021 through 2025.\n\nPalantir shares once rose nearly 5% in premarket trading.","news_type":1,"symbols_score_info":{"PLTR":0.9}},"isVote":1,"tweetType":1,"viewCount":3465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844412695,"gmtCreate":1636451155235,"gmtModify":1636455795644,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Pay day!","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Pay day!","text":"$Palantir Technologies Inc.(PLTR)$Pay day!","images":[{"img":"https://static.tigerbbs.com/39f5d602b05e634df1b378548a609fb0","width":"750","height":"2567"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844412695","isVote":1,"tweetType":1,"viewCount":3780,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844341062,"gmtCreate":1636396890468,"gmtModify":1636396890638,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Share share","listText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Share share","text":"$Pinterest, Inc.(PINS)$Share share","images":[{"img":"https://static.tigerbbs.com/9c182b95564d66208c97e2677672c2fc","width":"750","height":"2557"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844341062","isVote":1,"tweetType":1,"viewCount":3347,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842281805,"gmtCreate":1636181663868,"gmtModify":1636181664021,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Share ","listText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Share ","text":"$Pinterest, Inc.(PINS)$Share","images":[{"img":"https://static.tigerbbs.com/0814ceec8bf114ea928080df8fe5a29a","width":"750","height":"2747"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842281805","isVote":1,"tweetType":1,"viewCount":2979,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846793967,"gmtCreate":1636111442688,"gmtModify":1636111442785,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Share","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>Share","text":"$Palantir Technologies Inc.(PLTR)$Share","images":[{"img":"https://static.tigerbbs.com/df82625bccca4b69cc0d7b8db8e2e937","width":"750","height":"2747"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846793967","isVote":1,"tweetType":1,"viewCount":3106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846790678,"gmtCreate":1636111208772,"gmtModify":1636111208918,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Too good to miss","listText":"<a href=\"https://laohu8.com/S/PINS\">$Pinterest, Inc.(PINS)$</a>Too good to miss","text":"$Pinterest, Inc.(PINS)$Too good to miss","images":[{"img":"https://static.tigerbbs.com/103cc76613c65f459e05d5c41be26f9c","width":"750","height":"1464"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846790678","isVote":1,"tweetType":1,"viewCount":3298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":848811455,"gmtCreate":1635988498720,"gmtModify":1635988498831,"author":{"id":"3579647754039667","authorId":"3579647754039667","name":"HoSei","avatar":"https://static.tigerbbs.com/b65f0852010eb87e540514cf7506961d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3579647754039667","authorIdStr":"3579647754039667"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>To the moon tonight ","listText":"<a href=\"https://laohu8.com/S/PLTR\">$Palantir Technologies Inc.(PLTR)$</a>To the moon tonight ","text":"$Palantir Technologies Inc.(PLTR)$To the moon tonight","images":[{"img":"https://static.tigerbbs.com/f3428097887558839f6c9a8958c06aae","width":"750","height":"1464"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848811455","isVote":1,"tweetType":1,"viewCount":2935,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}